ArticleJournal of molecular medicine (Berlin, Germany)2026

Liver specific-inhibition of LPCAT3 ameliorates metabolic dysfunction-associated steatotic liver disease.

Vijay Kondreddy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.